Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?

Pharmacopsychiatry - 1 May 1999

Dettling M, Cascorbi I, Hellweg R, Deicke U, Weise L, Müller-Oerlinghausen B

Abstract excerpt

Whether or not olanzapine causes bone marrow toxicity is still a matter of debate. In spite of pre-marketing and post-marketing clinical trials, and although there have been no cases in animals of olanzapine-induced neutropenia or agranulocytosis, the risk of bone marrow toxicity cannot be exclud...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines
Share to Genetic Predisposition to Disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Haplotypes

Share to HLA Antigens

Share to Olanzapine

Source

Identifiers

PMID: 10463379
DOI: 10.1055/s-2007-979204

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-10463379-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic determinants of drug-induced agranulocytosis: potential risk of olanzapine?PMID 10463379Read ↗

Clozapine-induced agranulocytosis and its genetic determinants.Semantic proximity Read ↗

Idiosyncratic drug-induced agranulocytosis: possible mechanisms and management.Semantic proximity Read ↗

[Clozapine-induced agranulocytosis: genetic risk factors and an immunologic explanatory model].Semantic proximity Read ↗

Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.Semantic proximity Read ↗

Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.Semantic proximity Read ↗

Drug-induced agranulocytosis: impact of different fcgamma receptor polymorphisms?Semantic proximity Read ↗

Pharmacogenomics of Clozapine-induced agranulocytosis: a systematic review and meta-analysis.Semantic proximity Read ↗

Clozapine-induced agranulocytosis and hereditary polymorphisms of clozapine metabolizing enzymes: no association with myeloperoxidase and cytochrome P4502D6.Semantic proximity Read ↗

Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population.Semantic proximity Read ↗

Genome-Wide Association Study of Metamizole-Induced Agranulocytosis in European Populations.Semantic proximity Read ↗

Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry.Semantic proximity Read ↗

Pharmacogenomic Study of Clozapine-Induced Agranulocytosis/Granulocytopenia in a Japanese Population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.